Description

Following the entry into force of the new Therapeutic Products Act (TPA, SR 812.21) and the revised Medicinal Products Licensing Ordinance (MPLO, SR 812.212.1), establishment licences for TPs, GTPs or GMOs granted from 1 January 2019 have been issued under the new legislation. Holders of establishment licences issued under the new legislation appear in the following list:

“Establishment licences for TPs, GTPs or GMOs issued under the new legislation”.

Resources